Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment for Intermediate Risk Neuroblastoma
NCT00003093Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Mar 1988
- Primary completion
- Sep 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 7
01
Overview
A Phase 3 trial of carboplatin, cyclophosphamide, doxorubicin, etoposide in neuroblastoma, sponsored by Children's Oncology Group. Started Mar 1988; status: completed.
02
Drugs
carboplatincyclophosphamidedoxorubicinetoposide
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00003093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003093.